(Q44264779)

1 December 2017

Women's angiographic vitamin and estrogen trial: design and methods (English)

1 reference

1 December 2017

1 reference

11

1 reference

1 December 2017

9

Jean Claude Tardif

1 reference

1 December 2017

Judith Hsia

1

1 reference

1 December 2017

Edwin L Alderman

2

1 reference

1 December 2017

Joel I Verter

3

1 reference

1 December 2017

William J Rogers

4

1 reference

1 December 2017

Paul Thompson

5

1 reference

1 December 2017

Barbara V Howard

6

1 reference

1 December 2017

Frederick R Cobb

7

1 reference

1 December 2017

Pamela Ouyang

8

1 reference

1 December 2017

Lyall Higginson

10

1 reference

1 December 2017

Ivan Barofsky

12

1 reference

1 December 2017

Michael Steffes

13

1 reference

1 December 2017

David J Gordon

14

1 reference

1 December 2017

Michael Proschan

15

1 reference

1 December 2017

Naji Younes

16

1 reference

1 December 2017

David Waters

17

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Contemporary Clinical Trials

1 December 2017

1 reference

1 December 2017

23

1 reference

1 December 2017

708-727

1 reference

1 December 2017

6

1 reference

The protective effects of estrogen on the cardiovascular system

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Estrogen replacement therapy and prognosis after first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effect on survival of estrogen replacement therapy after coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Estrogen replacement therapy after coronary angioplasty in women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Dietary antioxidants and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin E consumption and the risk of coronary disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin C intake and mortality among a sample of the United States population.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Antioxidants and atherosclerotic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

The run-in period in clinical trials. The effect of misclassification on efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Coronary artery quantitation and data management system for paired cineangiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Close relation of endothelial function in the human coronary and peripheral circulations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Acute vascular effects of estrogen in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Estrogen replacement reverses endothelial dysfunction in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Antioxidant vitamin C improves endothelial dysfunction in chronic smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effects of vitamin E on chronic and acute endothelial dysfunction in smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Tests for Linear Trends in Proportions and Frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Unstable angina and progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Prognostic significance of progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Compensatory enlargement of human atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2802%2900237-4

7 January 2021

10.1016/S0197-2456(02)00237-4

Identifiers

DOI

1 reference

1 December 2017

1 reference